Price Alert

Globus Medical Inc. (GMED)

NYSE: GMED · Real-Time Price · USD

60.48

2.42 (4.17%)

At close: Oct 03, 2025, 3:59 PM

60.73

0.40%

After-hours: Oct 03, 2025, 06:20 PM EDT

Globus Medical Statistics

Share Statistics

Globus Medical has 135.05M shares outstanding. The number of shares has increased by -0.82% in one year.

Shares Outstanding	135.05M
Shares Change (YoY)	-0.82%
Shares Change (QoQ)	-0.25%
Owned by Institutions (%)	82.9%
Shares Floating	134.08M
Failed to Deliver (FTD) Shares	14,326
FTD / Avg. Volume	0.96%

Short Selling Information

The latest short interest is 6.59M, so 4.88% of the outstanding shares have been sold short.

Short Interest	6.59M
Short % of Shares Out	4.88%
Short % of Float	6.55%
Short Ratio (days to cover)	6.43

Valuation Ratios

The PE ratio is 109.01 and the forward PE ratio is 15.91. Globus Medical's PEG ratio is -3.6.

PE Ratio	109.01
Forward PE	15.91
PS Ratio	4.46
Forward PS	2.7
PB Ratio	2.69
P/FCF Ratio	27.7
PEG Ratio	-3.6

Financial Ratio History

Enterprise Valuation

Globus Medical has an Enterprise Value (EV) of 10.98B.

EV / Sales	4.36
EV / EBITDA	23.18
EV / EBIT	21.09
EV / FCF	27.09

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.13.

Current Ratio	2.54
Quick Ratio	1.77
Debt / Equity	0.13
Debt / EBITDA	1.13
Debt / FCF	1.33
Interest Coverage	39.63

Financial Efficiency

Return on Equity is 2.47% and Return on Invested Capital is 2.92%.

Return on Equity	2.47%
Return on Assets	1.96%
Return on Invested Capital	2.92%
Revenue Per Employee	$475.35K
Profits Per Employee	$19.43K
Employee Count	5,300
Asset Turnover	0.48
Inventory Turnover	1.57

Taxes

Income Tax	17.74M
Effective Tax Rate	14.69%

Stock Price Statistics

The stock price has increased by -14.41% in the last 52 weeks. The beta is 1.12, so Globus Medical's price volatility has been higher than the market average.

Beta	1.12
52-Week Price Change	-14.41%
50-Day Moving Average	58.04
200-Day Moving Average	68.69
Relative Strength Index (RSI)	60.48
Average Volume (20 Days)	1,498,656

Income Statement

In the last 12 months, Globus Medical had revenue of 2.52B and earned 102.98M in profits. Earnings per share was 0.76.

Revenue	2.52B
Gross Profit	1.48B
Operating Income	165.99M
Net Income	102.98M
EBITDA	473.73M
EBIT	219.7M
Earnings Per Share (EPS)	0.76

Full Income Statement

Balance Sheet

The company has 784.44M in cash and 537.19M in debt, giving a net cash position of 247.25M.

Cash & Cash Equivalents	784.44M
Total Debt	537.19M
Net Cash	247.25M
Retained Earnings	1.15B
Total Assets	4.96B
Working Capital	1.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 520.64M and capital expenditures -115.43M, giving a free cash flow of 405.21M.

Operating Cash Flow	520.64M
Capital Expenditures	-115.43M
Free Cash Flow	405.21M
FCF Per Share	2.99

Full Cash Flow Statement

Margins

Gross margin is 58.9%, with operating and profit margins of 6.59% and 4.09%.

Gross Margin	58.9%
Operating Margin	6.59%
Pretax Margin	4.79%
Profit Margin	4.09%
EBITDA Margin	18.8%
EBIT Margin	6.59%
FCF Margin	16.08%

Dividends & Yields

GMED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	0.92%
FCF Yield	3.61%

Dividend Details

Analyst Forecast

The average price target for GMED is $91, which is 50.5% higher than the current price. The consensus rating is "Buy".

Price Target	$91
Price Target Difference	50.5%
Analyst Consensus	Buy
Analyst Count	13

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$3.8
Lynch Upside	-93.72%
Graham Number	22.92
Graham Upside	-62.1%

Scores

Altman Z-Score	8.13
Piotroski F-Score	7